This page collects WhisperX intelligence signals tagged #diabetes. It is designed for humans, search engines, and AI agents: each item links to a canonical source-backed record with sector, source, timestamp, credibility, and exportable structured data.
The Food and Drug Administration (FDA) on Tuesday sent 30 telehealth companies warning letters about their 'illegal' sales of compounded GLP-1s, building off increasing pressure to tamp down on the unauthorized distribution of these popular weight-loss and diabetes drugs. The agency stated these companies are illegally...
The U.S. Food and Drug Administration (FDA) has taken regulatory action against 30 telehealth companies for disseminating false and misleading information regarding compounded versions of GLP-1 receptor agonist drugs. These drugs, which include semaglutide and liraglutide, are approved for weight management and type 2 ...
The U.S. Food and Drug Administration (FDA) is escalating its enforcement campaign against the compounding of GLP-1 receptor agonist drugs, such as semaglutide and tirzepatide, which are widely used for weight loss and diabetes. In a significant move, the agency has issued a fresh batch of 30 warning letters to telehea...
Maryland has taken a direct step to control drug costs, with its Prescription Drug Affordability Board setting an upper payment limit for a widely prescribed diabetes treatment. This marks only the second time a state panel has taken such an action, positioning Maryland at the forefront of a contentious state-level pus...